Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1852-1856
doi: 10.1161/hq1001.097021
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haramaki, N.
Right arrow Articles by Imaizumi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haramaki, N.
Right arrow Articles by Imaizumi, T.
Related Collections
Right arrow Risk Factors
Right arrow Antiplatelets
Right arrow Coagulation and fibronolysis
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1852.)
© 2001 American Heart Association, Inc.


Thrombosis

Long-Term Smoking Causes Nitroglycerin Resistance in Platelets by Depletion of Intraplatelet Glutathione

Nobuya Haramaki; Hisao Ikeda; Yoshinori Takajo; Atsushi Katoh; Seiji Kanaya; Satoshi Shintani; Reiko Haramaki; Toyoaki Murohara; Tsutomu Imaizumi

From the Departments of Internal Medicine III (N.H., H.I., Y.T., A.K., S.K., S.S., T.I.) and Nephrology (R.H.) and the Cardiovascular Research Institute (T.M.), Kurume University School of Medicine, Kurume, Japan.

Correspondence to Nobuya Haramaki, MD, PhD, Department of Internal Medicine III, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. E-mail haramaki{at}med.kurume-u.ac.jp

Abstract— We investigated whether platelet responsiveness to nitroglycerin (NTG) is maintained in long-term smokers and if not, the mechanism. In the absence or presence of NTG, intraplatelet reduced glutathione (GSH) levels and ADP-induced platelet aggregation and intraplatelet cGMP levels were measured in 10 long-term smokers and 10 age-matched nonsmokers. The intraplatelet GSH level was significantly lower in smokers than in nonsmokers (P<0.05). Platelet aggregation was dose-dependently inhibited by NTG in both groups; however, inhibition was significantly weaker in smokers. N-acetylcysteine (1 mmol/L), an exogenous thiol agent, significantly potentiated NTG-induced platelet inhibition in nonsmokers but not in smokers. The ADP-induced intraplatelet cGMP level was significantly greater in the presence of NTG in nonsmokers but not so in smokers. Because the effects of long-term smoking are multifactorial, a rabbit model was made by chronic administration of buthionine sulfoximine (BSO, n=6) to decrease intraplatelet GSH. The intraplatelet GSH level was significantly lower in BSO-treated rabbits than in saline-treated rabbits (P<0.001). The NTG-induced inhibition of platelet aggregation was significantly weaker in BSO rabbits. N-acetylcysteine–induced potentiation was not observed in BSO rabbits, whereas significant potentiation was found in saline rabbits. These findings were similar to those of long-term smokers. In contrast, the intraplatelet GSH-to–oxidized glutathione ratio, which represents the redox state of glutathione, was significantly lower in smokers than in nonsmokers, whereas no difference was found between saline rabbits and BSO rabbits. In conclusion, long-term smoking causes NTG resistance to aggregation in platelets, possibly through the depletion of intraplatelet GSH.


Key Words: smoking • nitroglycerin • platelets • glutathione • cGMP




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Haramaki, H. Ikeda, K. Takenaka, A. Katoh, R. Sugano, S.-i. Yamagishi, H. Matsuoka, and T. Imaizumi
Fluvastatin Alters Platelet Aggregability in Patients With Hypercholesterolemia: Possible Improvement of Intraplatelet Redox Imbalance via HMG-CoA Reductase
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1471 - 1477.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Morita, H. Ikeda, N. Haramaki, H. Eguchi, and T. Imaizumi
Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers
J. Am. Coll. Cardiol., February 15, 2005; 45(4): 589 - 594.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Krotz, H.-Y. Sohn, and U. Pohl
Reactive Oxygen Species: Players in the Platelet Game
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
F. L Ruberg and J. Loscalzo
Prothrombotic determinants of coronary atherothrombosis
Vascular Medicine, November 1, 2002; 7(4): 289 - 299.
[Abstract] [PDF]